US-based intraocular lens developer PowerVision closed its series C round at $37.2m it has emerged, as it added Johnson & Johnson Development Corporation (JJDC) to its pool of investors, on 22nd December. JJDC joined venture capital (VC) firms Advanced Technology Ventures, Venrock and Frazier Healthcare Ventures, all existing investors, in the round’s final closing. Medical…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.